Laurel Beckett is a biostatistician with extensive experience in medical research. She works with scientists in designing, evaluating and analyzing a wide range of studies, including clinical trials, population health studies and basic science investigations. Her areas of specialty include Alzheimer's disease, other chronic diseases of aging and cancer clinical trials. She has held consulting positions with Stanford Medical School, the New York Public Health Department, and Brookhaven National Laboratory. Previous faculty positions include Rush University, Harvard University, Texas AM University, and SUNY Stony Brook. She also is a member of the scientific advisory board for the Alzheimer's Disease Centers at UC San Diego and Washington University, and the Consortium Against Major Diseases. A research specialist, Beckett does not see patients.
Ph.D., Stanford University, Palo Alto, California, 1972
M.S., Stanford University School of Medicine, Palo Alto, California, 1969
B.A., Pomona College, Claremont, California, 1968
American Statistical Association
Institute of Mathematical Statistics
Honors and Awards
Mentor Award from School of Medicine. Outstanding Research by a trainee, Academy of Breastfeeding Medicine, Academy of Breastfeeding Medicine for Outstanding Research by a Trainee for work carried out under Dr. Beckett’s supervision by Naomi Saiot, and undergraduate trainee in statistics working through the CTSC with Shontae Buffington, a resident in Family Medicine., 2007
Fellow, American Statistical Association, 2004
Outstanding Faculty Award, Graduate Group in Epidemiology, 2003
Dean's Award for Faculty Mentoring, 2002
Select Recent Publications
Han SD; Gruhl J; Beckett LA; Dodge H; Stricker HH; Farias S; Mungas D. Beta amyloid, Tau, Neuroimaging, and Cognition: Sequence Modeling of Biomarkers for Alzheimer's Disease. Brain Imaging and Behavior. (4)2012
Howell L, Beckett L, Nettiksimmons J, Villablanca A. Generational and Gender Perspectives on Career Flexibility: Ensuring the Faculty Workforce of the Future. The American Journal of Medicine, 2012 125(7): 719-728.
Nettiksimmons J, Beckett L, DeCarli C, Carmichael O, Schwartz C, Fletcher E. Subgroup of ADNI normal controls characterized by atrophy and cognitive decline associated with vascular damage. Psychology and Aging 2012
Norman SA, Goertz CE, Burek KA, Quakenbush LT, Cornick LA, Romano TA, Spoon T, Miller W, Beckett LA, Hobbs RC. Seasonal Hematologyand Serum Chemistry of Wild Beluga Whales (Delphinapterus Leucas) in Bristol Bay, Alaska. Journal of Wildlife Diseases, 2012 1(48): 21-32.
Sangha R, Davies AM, Lara PN Jr, Mack PC, Beckett LA, Hesketh PJ, Lau D, Li T, Perkins N, Gandara DR. Intercalated Erlotinib- Docetaxel Dosing Schedules Designed to Achieve Pharmacodynamic Separation:Results of a Phase 1/11 Trial. Journal of Thoracic Oncology, 2011 6(12):2112-2119.
Sperling RA, Aisen PS, Beckett LA, Bennett DA, Cragt S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH. Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s Disease. Alzheimer’s Dement. 2011 May; 7(3): 280-92. Epub 2011 Apr
Villablanca AC, Beckett L, Nettiksimmons J, Howell LP. Career Flexibility and Family-Friendly Policies: An NIH-Funded Study to Enhance Women's Careers in Biomedical Sciences. Journal of Women's Health. 2011 20(10): 1485-1496.
Meyers F, Carducci J, Linder J, Loscalzo M, Beckett LA. Effects of a problem-solving intervention (COPE) on quality of life for advanced cancer patients on clinical trials and their caregivers: Simultaneous Care Educational Intervention (SCEI): Linking Palliation and Clinical Trials. Journal of Palliative Medicine. 2011 Apr;14(4):456-73.
Henderson PT, Li T, He M, Zhang H, Malfatti M, Gandara D, Grimminger PP, Danenberg KD, Beckett L, de Vere White RW, Turteltaub KW, Pan CX. A microdosing approach for characterizing formation and repair of carboplatin-DNA monoadducts and chemoresistance. International Journal of Cancer, 2011 129(6): 1425-1434.
Boyce W, Shender L, Schultz L, Vickers W, Johnson C, Ziccardi M, Beckett L, Padgett K, Crosbie P, Sykes J. Survival analysis of dogs diagnosed with canine peritoneal larval cestodiasis (Mesocestoides spp.). Vet Parasitol. 2011 Aug 25;180(3-4):256-61. Epub 2011 Mar 24.